Legal Representation
Attorney
Viviana Amzel
USPTO Deadlines
Application History
31 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Sep 13, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Sep 13, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Dec 29, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 29, 2005 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Dec 29, 2005 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jul 1, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 1, 2005 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 1, 2005 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jan 10, 2005 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Dec 23, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 23, 2004 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jul 29, 2004 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jul 19, 2004 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 16, 2004 | I | PAPER RECEIVED | Loading... | |
Jul 13, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
Jul 6, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 6, 2004 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jan 29, 2004 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jan 7, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 7, 2004 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 8, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 15, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 26, 2003 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Jul 18, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jul 5, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 5, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 29, 2001 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
Aug 17, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 12, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Jan 24, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 23, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Medical diagnostic and therapeutic preparations and devices, for administering same, sold filled, with, diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostrate included
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
EPIGENESIS
Classification
International Classes
005